A detailed history of Nisa Investment Advisors, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,242 shares of INVA stock, worth $24,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,242
Previous 1,209 2.73%
Holding current value
$24,219
Previous $18,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$14.4 - $16.4 $475 - $541
33 Added 2.73%
1,242 $20,000
Q1 2024

May 01, 2024

BUY
$14.56 - $16.78 $1,004 - $1,157
69 Added 6.05%
1,209 $18,000
Q3 2023

Nov 02, 2023

SELL
$12.37 - $13.89 $247 - $277
-20 Reduced 1.72%
1,140 $14,000
Q2 2023

Aug 11, 2023

BUY
$11.39 - $13.72 $341 - $411
30 Added 2.65%
1,160 $14,000
Q1 2023

May 02, 2023

SELL
$10.73 - $13.6 $364 - $462
-34 Reduced 2.92%
1,130 $13,000
Q3 2022

Nov 07, 2022

BUY
$11.61 - $15.22 $626 - $821
54 Added 4.86%
1,164 $16,000
Q2 2022

Aug 03, 2022

BUY
$14.32 - $19.88 $15,895 - $22,066
1,110 New
1,110 $16,000
Q1 2022

Apr 29, 2022

SELL
$15.39 - $20.25 $236,559 - $311,262
-15,371 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$15.91 - $18.72 $40,634 - $47,810
2,554 Added 19.93%
15,371 $246,000
Q3 2021

Oct 18, 2021

BUY
$13.06 - $17.24 $167,390 - $220,965
12,817 New
12,817 $214,000
Q3 2020

Oct 20, 2020

SELL
$10.33 - $14.49 $117,679 - $165,070
-11,392 Closed
0 $0
Q2 2020

Jul 27, 2020

SELL
$11.49 - $15.26 $261,949 - $347,897
-22,798 Reduced 66.68%
11,392 $159,000
Q3 2019

Oct 17, 2019

BUY
$10.05 - $14.55 $5,889 - $8,526
586 Added 1.74%
34,190 $360,000
Q1 2019

Apr 17, 2019

BUY
$13.69 - $20.06 $448,949 - $657,847
32,794 Added 4048.64%
33,604 $471,000
Q3 2018

Oct 16, 2018

BUY
$13.63 - $15.7 $2,180 - $2,512
160 Added 24.62%
810 $12,000
Q1 2018

Apr 10, 2018

SELL
$13.8 - $16.99 $3,450 - $4,247
-250 Reduced 27.78%
650 $11,000
Q3 2017

Oct 13, 2017

BUY
$12.06 - $14.12 $10,854 - $12,708
900
900 $13,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.36B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.